THE SAFETY, TOLERABILITY AND EFFICACY OF ZOELY (NOMEGESTROL ACETATE /ESTRADIOL) FOR MENSTRUALLY-RELATED MIGRAINE (ACTRN12625000644460)
ZOELY FOR MENSTRUALLY-RELATED MIGRAINE
This trial is Coming soon
Registration number ACTRN12625000644460
Program & service
This trial is being run with the Brain service, and as part of the Neurology program.
Trial phase
Pilot
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Dr Lakshini Gunasekera
Key inclusion data
Inclusion: Aged 18-40 years at time of enrolment, current diagnosis of MRM without aura (ICHD-3 criteria), no change in migraine treatment in the preceding 3 months prior to enrolment and for the duration of the study, and no contraindications to hormonal therapy. Exclusion: Aged over 40 years, migraine with aura, history of ischemic cerebral infarct/ stroke, history of thrombosis or blood clots, known disorder affecting blood clotting, history of breast, uterine or ovarian cancer, undiagnosed vaginal bleeding, liver disease, opioid medication overuse, pregnancy or plans to become pregnant during study period, or currently breastfeeding.More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTRIf you would like further details or have any questions about this clinical trial, we encourage you to get in touch with us and a member of our team will be happy to provide you with more information.